Premature ventricular contraction laboratory findings: Difference between revisions
Created page with "__NOTOC__ {{Premature ventricular contraction}} {{CMG}}; {{AE}} {{M.P}} ==Overview== Many cases of premature ventricular contraction have no definite cause, it may be the re..." |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
* [[ABG]] : To rule out [[hypercapnia]] and [[hypoxia]]. | * [[ABG]] : To rule out [[hypercapnia]] and [[hypoxia]]. | ||
* [[Thyroid-stimulating hormone]] : To rule out [[hyperthyroidism]] and of relevance if [[amiodarone]] is administered for treatment. | * [[Thyroid-stimulating hormone]] : To rule out [[hyperthyroidism]] and of relevance if [[amiodarone]] is administered for treatment. | ||
==2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)<ref name="Al-KhatibStevenson2018">{{cite journal|last1=Al-Khatib|first1=Sana M.|last2=Stevenson|first2=William G.|last3=Ackerman|first3=Michael J.|last4=Bryant|first4=William J.|last5=Callans|first5=David J.|last6=Curtis|first6=Anne B.|last7=Deal|first7=Barbara J.|last8=Dickfeld|first8=Timm|last9=Field|first9=Michael E.|last10=Fonarow|first10=Gregg C.|last11=Gillis|first11=Anne M.|last12=Granger|first12=Christopher B.|last13=Hammill|first13=Stephen C.|last14=Hlatky|first14=Mark A.|last15=Joglar|first15=José A.|last16=Kay|first16=G. Neal|last17=Matlock|first17=Daniel D.|last18=Myerburg|first18=Robert J.|last19=Page|first19=Richard L.|title=2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death|journal=Circulation|volume=138|issue=13|year=2018|issn=0009-7322|doi=10.1161/CIR.0000000000000549}}</ref>== | |||
==References== | ==References== | ||
Revision as of 15:47, 16 April 2020
|
Premature ventricular contraction Microchapters |
|
Differentiating Premature Ventricular Contraction from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Premature ventricular contraction laboratory findings On the Web |
|
FDA on Premature ventricular contraction laboratory findings |
|
Premature ventricular contraction laboratory findings in the news |
|
Blogs on Premature ventricular contraction laboratory findings |
|
to Hospitals Treating Premature ventricular contraction laboratory findings |
|
Risk calculators and risk factors for Premature ventricular contraction laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Many cases of premature ventricular contraction have no definite cause, it may be the result of various other problems. If PVC patients present with symptoms, a generalized approach is done to find the precipitating factors.
Laboratory Findings
The following investigations are done to patients with symptoms :
- Renal function and electrolytes
- Complete blood count
- ABG : To rule out hypercapnia and hypoxia.
- Thyroid-stimulating hormone : To rule out hyperthyroidism and of relevance if amiodarone is administered for treatment.
2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)[1]
References
- ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.